bioRxivNeurosciencePreprint
Loss of PINK1 causes age-dependent mitochondrial trafficking deficits in nigrostriatal dopaminergic neurons through aberrant activation of p38 MAPK
Jingyu ZhaoiD, Yuanxin CheniD, Lianteng Zhi, Qing Xu, Hui ZhangiD, Chenjian LiiD
Abstract
Mutations in PTEN-induced putative kinase 1 (PINK1) cause early-onset, autosomal-recessive Parkinsons disease (PD). While previous studies showed age-related declines in dopamine release and ATP levels in Pink1-/- mice, the mechanisms remain unclear. Using a novel TH-Mito-Dendra2 transgenic mouse model to label dopaminergic neuron mitochondria, it is found that PINK1 loss leads to age-dependent deficits in mitochondrial axonal trafficking, characterized by reduced anterograde movement and increased static mitochondria in acute brain slices, which more closely mimic in vivo conditions. Pharmacological induction of reactive oxygen species (ROS) and calcium release impaired mitochondrial mobility. Pink1 knockout mice exhibited elevated mitochondrial calcium, ROS levels, and p38 MAPK hyperactivation. Treatment with p38 inhibitor SB202190 restored mitochondrial motility and increased anterograde transport. Our findings suggest that PINK1 loss disrupts mitochondrial trafficking by disturbing calcium homeostasis and ROS production via the p38 pathway, contributing to PD pathogenesis. Table of Contents O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=181 SRC="FIGDIR/small/602426v3_ufig1.gif" ALT="Figure 1"> View larger version (68K): org.highwire.dtl.DTLVardef@1352742org.highwire.dtl.DTLVardef@a48086org.highwire.dtl.DTLVardef@1f209daorg.highwire.dtl.DTLVardef@164ed23_HPS_FORMAT_FIGEXP M_FIG C_FIG Using a novel mouse model with labeled dopaminergic neuron mitochondria, Zhao J. et al. discovered age dependent disruptions in mitochondrial transport. Their research showed progressive deterioration of mitochondrial movement, characterized by reduced anterograde movement and increased static mitochondria. These changes were associated with higher oxidative stress and hyperactivation of p38 MAPK in Parkinsons disease.
- organism: mouse
- assay: spatial transcriptomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: trajectory inference
- research focus: cell-cell communication
- approach: experimental assay
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- PINK1 Regulates Dopamine and Lipids at Mitochondria to Maintain Synapses and Neuronal Function
Christine Bus, Sven Geisler, … Julia Catherine Fitzgerald·bioRxiv·Oct 22, 2019
- Defects in Mitochondrial Biogenesis Drive Mitochondrial Alterations in PINK1-deficient Human Dopamine Neurons
Hu Wang, Rong Chen, … Ted M. Dawson·bioRxiv·Jun 23, 2023
- Aging hastens locomotor decline in PINK1 knockout rats in association with decreased nigral, but not striatal, dopamine and tyrosine hydroxylase expression
Isabel Soto, Robert McManus, … Michael F. Salvatore·Experimental NeurologyPeer-reviewed·Jun 1, 2024
- ROCK1/Drp1-mediated aberrant mitochondrial fission is crucial for dopaminergic nerve cell apoptosis
Qian Zhang, Changpeng� Hu, … Rong Zhang·bioRxiv·Jul 10, 2018
- Parkinson's disease-related Miro1 mutation induces mitochondrial dysfunction and loss of dopaminergic neurons in vitro and in vivo
Axel Chemla, Giuseppe Arena, … Cláudia Saraiva·BrainPeer-reviewed·Feb 5, 2025
- Preserved striatal innervation and motor function despite severe loss of nigral dopamine neurons following mitochondrial dysfunction induced by mtDNA mutations
Thomas Paß, Konrad M. Ricke, … Rudolf J. Wiesner·bioRxiv·Jul 7, 2023